A proof-of-concept study on the use of prostate artery embolization prior to de nitive radiotherapy in prostate cancer

Jeffrey Peacock H Lee Mo tt Cancer Center and Research Institute https://orcid.org/0000-0002-0725-5925 Dhiraj Sikaria USF Health Morsani College of Medicine Laura Maun-Garcia H Lee Mo tt Cancer Center and Research Institute Khosrow Javedan H Lee Mo tt Cancer Center and Research Institute Kosj Yamoah H Lee Mo tt Cancer Center and Research Institute Nainesh Parikh (  Nainesh.parikh@mo tt.org ) Interventional Radiology, Mo tt Cancer Center, Florida, USA https://orcid.org/0000-0001-7563-8605

[1]  T. Bilhim,et al.  Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia. , 2020, Journal of vascular and interventional radiology : JVIR.

[2]  J. Pisco,et al.  Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia. , 2019, European urology.

[3]  L. Lönn,et al.  Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series , 2019, CardioVascular and Interventional Radiology.

[4]  T. Wilt,et al.  Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline , 2018, The Journal of urology.

[5]  T. Kessler,et al.  Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial , 2018, British Medical Journal.

[6]  D. Engeler,et al.  Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. , 2018, Journal of vascular and interventional radiology : JVIR.

[7]  J. Patrie,et al.  Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic Hyperplasia. , 2016, Journal of vascular and interventional radiology : JVIR.

[8]  Yan Wang,et al.  Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population , 2015, BMC Urology.

[9]  Y. Yoshioka,et al.  Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis , 2014, Journal of radiation research.

[10]  A. Olumi,et al.  Personalized medicine for the management of benign prostatic hyperplasia. , 2014, The Journal of urology.

[11]  Yi Wang,et al.  Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial. , 2014, Radiology.

[12]  P. Manser,et al.  Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking , 2008, Radiation oncology.

[13]  Xiong-Zhi Wu,et al.  Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.

[14]  Rainer Hofmann,et al.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. , 2006, European urology.

[15]  M. Srougi,et al.  Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. , 2015, Journal of vascular and interventional radiology : JVIR.